...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A couple Q2 events for Zenith

ASCO June 2-6, 2017 in Chicago. Might only be attending. No abstract/title found in program search.

BIO International June 19-22, 2017 in San Diego. Presenting.

Share
New Message
Please login to post a reply